# Regions Financial Corp: overview

RF · NYSE · CIK 1281761 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rf.md) · [Financials](/companies/rf/financials.md) · [Filings](/companies/rf/filings.md) · [Insiders](/companies/rf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.49](/filings/0001281761-25-000080.md) | not reported | [0.51](/filings/0001281761-26-000037.md) | [0.59](/filings/0001281761-26-000055.md) | [0.61](/filings/0001281761-25-000080.md) | not reported | [0.62](/filings/0001281761-26-000037.md) | [0.64](/filings/0001281761-26-000055.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [104](/filings/0001281761-22-000016.md) | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [44.2%](/filings/0001281761-24-000010.md) | not reported | not reported | not reported | not reported |
| Net margin | % | [2424.0%](/filings/0001281761-24-000010.md) | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.49](/filings/0001281761-24-000010.md) | [2.28](/filings/0001281761-25-000010.md) | [2.11](/filings/0001281761-26-000019.md) | [1.93](/filings/0001281761-26-000019.md) | [2.30](/filings/0001281761-26-000019.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.46bn | 81,326,428 |  | Reduced −891,918 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.68bn | 55,724,527 |  | Reduced −440,273 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.54bn | 50,667,092 |  | Added +2,953,594 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.20bn | 39,837,734 |  | Reduced −279,674 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $838.8m | 27,773,516 |  | Added +2,201,798 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $725.9m | 24,125,742 |  | Added +40,947 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $634.0m | 20,992,390 |  | Reduced −15,144,333 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $561.3m | 18,585,587 |  | Added +720,577 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $560.1m | 18,544,746 |  | Added +5,185,777 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $544.2m | 17,977,505 |  | Reduced −36,853 |

## Recent filings

[All 2,747 filings](/companies/rf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 10:01 ET | [8-K](/filings/0001281761-26-000063.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001281761-26-000063 |
| 2026-08-11 | 13:02 ET | [8-K](/filings/0001281761-26-000060.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001281761-26-000060 |
| 2026-08-07 | 20:12 ET | [8-K](/filings/0001281761-26-000057.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001281761-26-000057 |
| 2026-08-06 | 17:10 ET | [10-Q](/filings/0001281761-26-000055.md) | Quarterly report, period 2026-06-30 | 0001281761-26-000055 |
| 2026-07-17 | 10:01 ET | [8-K](/filings/0001281761-26-000050.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001281761-26-000050 |
| 2026-05-11 | 21:00 ET | [8-K](/filings/0001281761-26-000042.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001281761-26-000042 |
| 2026-05-11 | 20:58 ET | [8-K](/filings/0001281761-26-000041.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001281761-26-000041 |
| 2026-05-07 | 15:53 ET | [10-Q](/filings/0001281761-26-000037.md) | Quarterly report, period 2026-03-31 | 0001281761-26-000037 |
| 2026-04-17 | 10:03 ET | [8-K](/filings/0001281761-26-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001281761-26-000032 |
| 2026-03-23 | 20:19 ET | [DEF 14A](/filings/0001281761-26-000027.md) | Proxy statement, period 2026-05-06 | 0001281761-26-000027 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001281761-26-000019.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1281761
- Tickers: RF, RF-PC, RF-PE, RF-PF
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.